Blockchain Registration Transaction Record
Neural Therapeutics CEO Ian Campbell Discusses Potential CSE Listing and Future Plans
Neural Therapeutics CEO Ian Campbell discusses the company's conditional approval to list on the Canadian Securities Exchange and the growing interest in psychedelic treatments. This move has the potential to impact mental health treatment and the investment landscape.
The conditional approval for Neural Therapeutics to list on the Canadian Securities Exchange represents a significant opportunity for the company to raise funds, accelerate drug development, and address the growing interest in psychedelic treatments. This move could have a substantial impact on mental health treatment and the investment landscape.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0x05abd6fc8f068d34d5a88ead492ecdf1431ea0723138041bce3a14cee665f453 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | deep67RL-6992b0ff26616ab16c87455e2c973375 |